Myeloproliferative Neoplasms News

The addition of an in-house specialty pharmacy at a cancer center in Connecticut reduced the amount of time patients waited for oral cancer medications; prevented errors associated with filling, dispensing and taking oral chemotherapy; and improved overall quality of care, according to a study being presented at the Quality Care Symposium.

Several cancer survivorship care models are available to help integrate primary care providers into the long-term follow-up care of cancer survivors.

A majority of patients with cancer and their caregivers lack sufficient knowledge about advances in diagnostic and treatment options, according to results of a survey released by Cancer Treatment Centers of America.

Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an analysis published in Cancer.

This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results.

Kenneth C. Anderson, MD, director of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute, took over as president of ASH in January.

Enrollment of adolescents in oncology trials remains significantly lower than that of children.

The use of metaphors for explaining randomization could ease the difficulty in recruiting patients to participate in randomized clinical trials, according to a study published in the Journal of the National Cancer Institute.

The board of directors for World Conference on Interventional Oncology, a nonprofit association that supports and promotes the field, has established a society to further its mission.

National Cancer Prevention Month, established by a U.S. Senate resolution and observed every February since 2004, is intended to draw attention to the fact that approximately 70% of malignancies may be prevented through diet or other lifestyle changes.